INJECTABLE PHARMACEUTICAL PREPARATION TREAT

Brand	Owner (click to sort)	Address	Description
CEREDASE	GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP	500 KENDALL STREET CAMBRIDGE MA 02142	INJECTABLE PHARMACEUTICAL PREPARATION TO TREAT AN INHERITED GENETIC DEFECT CAUSED BY AN ENZYME DEFICIENCY;
CEREZYME	GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP	500 KENDALL STREET CAMBRIDGE MA 02142	injectable pharmaceutical preparation to treat an enzyme deficiency caused by a genetic defect;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

Injectable compositions containing gabapentin and processes for preparing sterile injectable compositions containing gabapentin are discussed. The process includes subjecting the compositions to heat. Heating results in increased production of gabapentin lactam, which has previously been shown to be toxic. Surprisingly, heated injectable compositions containing gabapentin are found to be non-toxic when administered intrathecally. Thus, heating for the purposes of sterilization or to assure sterility provides a viable option in the production of injectable compositions containing gabapentin.